Baseline ALBI score and early variation of serum AFP predicts outcomes in patients with HCC treated by atezolizumab–bevacizumab. - Campani, Claudia; Bamba‐Funck, Jessica; Campion, Bertille; Sidali, Sabrina; Blaise, Lorraine; Ganne‐Carrié, Nathalie; Demory, Alix; Sutter, Olivier; Larrey, Edouard; Evain, Manon; Ghannouchi, Haroun; Wagner, Mathilde; et al. (Liver International, 2023)